ECOG E2100 - Cancer Therapy Evaluation Program (CTEP)
ECOG E2100 - Cancer Therapy Evaluation Program (CTEP)
ECOG E2100 - Cancer Therapy Evaluation Program (CTEP)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bevacizumab increased grade 3/4 toxicity<br />
Serious but rare<br />
Serious, frequent, & unique<br />
Likely related to duration of taxane exposure<br />
Toxicity P (%) P+B (%) p-value<br />
Infection 2.9 9.3